CoChat

Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

We have surveyed the incidence of adult T‐cell leukemia/lymphoma (ATLL) in an endemic area of 290,464 inhabitants for 7 years. We now revise our previous results on the basis of additional findings and estimate the age‐ and sex‐specific cumulative rate for HTLV‐I carriers, the adoption of which is recommended by current cancer epidemiology as a new age‐standardized incidence rate. An unequivocal age‐dependent increase in seroprevalence was observed for both sexes with a characteristic predominance in females. The age‐dependent seroconversion in females may be partly explained by additional infection from infected husbands to their wives but the reason for men remains obscure. The mean annual number of incident cases of ATLL was 11.4, giving 3.9 ATLL patients annually per 10 5 inhabitants, 6.1 per 10 5 inhabitants aged over 30, and 85.0 per 10 5 seropositives aged over 30. Crude annual incidence rate of ATLL among 10 5 male seropositives aged over 30 was 145.3 and that for females was 55.2 and 95% confidence intervals of ATLL incidence rates were 34.8 to 255.7 for males and 6.4 to 104.1 for females, respectively. Although the sex ratio of 80 ATLL patients was 1.35, males are more prone to the disease (46 male patients among 4,522 male seropositives aged over 30 vs. 34 female patients among 8,801 female seropositives aged over 30; p < 0.001) for unknown reason(s). Morbidity in male seropositives aged over 30 is 2.6 times as high as that of females. Decennial incidence rates in males in their fifties and sixties were significantly higher than those in females. The remarkable male preponderance in oncogenicity of HTLV‐I may be due to the fact that men are more prone to the disease and the number of female carriers in the denominator used to calculate the incidence rate is larger than that of males. The whole life span (0–79) cumulative risk for males was 6.9% and significantly higher than that of females (2.95%).

Overview

Integrity signals

Registry

Crossref · 10.1002/ijc.2910430618

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 15 references

Research works printed but not linked: 6

  1. Beasley R. P., 1982, Hepatitis B virus as the etiologic agent in hepatocellular carcinoma—epidemiologic considerations, Hepatology, 2, 21
  2. Kinoshita K., 1985, Annual incidence of adult T‐Cell leukemia‐Lymphoma (aTLL) from ATL virus‐Carriers in Nagasaki Prefecture, Nagasaki Igakkai Zasshi, 60, 56
  3. Kondo T., 1987, Risk of adult T‐Cell leukemia/Lymphoma in HTLV‐I carriers, Lancet, 18
  4. Kondo T., 1985, Epidemiology of ATLL and preceding stages, Rec. Advanc. RES Res., 25, 156
  5. Prince A. M., 1982, The risk of development of hepatocellular carcinoma in hepatitis B virus carriers in New York. A preliminary estimate using death‐Records matching, Hepatology, 2, 15
  6. Tajima K., 1982, Epidemiological analysis of the distribution of antibody to adult T‐Cell leukemia‐Virus‐Associated antigen (aTLA): possible horizontal transmission of adult T‐Cell leukemia virus, Gann, 73, 893

Cited by

See all 125

Metadata

Authors
Kondo, T., Kono, H., Miyamoto, N., Yoshida, R., Toki, H., Matsumoto, I., Hara, M., Inoue, H., Inatsuki, A., Funatsu, T., Yamano, N., Bando, F., Iwao, E., Miyoshi, I., Hinuma, Y., & Hanaoka, M.
Affiliations
  • University of Kochi (JP)
  • Shionogi (Japan) (JP)
  • Kyoto University (JP)
Corresponding author
Kondo, Toshifumi
Venue
International Journal of Cancer
Publisher
Wiley
Published
1989-06-15
Volume
43
Issue
6
Pages
1061-1064
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W1981664147
Cited by
118
References
15
Citations by year
2026: 1 · 2025: 3 · 2024: 4 · 2023: 2 · 2022: 1 · 2021: 7 · 2020: 6 · 2019: 1 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 4 · 2014: 5 · 2013: 4 · 2012: 5
FWCI
2.47
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Cancer (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
  • Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
Keywords
adult T-cell leukemia/lymphoma, HTLV-1 infection, age-standardized incidence rate, cumulative incidence, sex differences, age-specific incidence, seroconversion, seroprevalence, male preponderance, oncogenicity, endemic areas
MeSH terms
Age Factors, Carrier State, Humans, Japan, Population Surveillance, Retrospective Studies, Risk Factors, Sex Factors, Leukemia-Lymphoma, Adult T-Cell, HTLV-I Antibodies, HTLV-I Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. https://app.cochat.ai/papers/10.1002/ijc.2910430618
The paper
Kondo, T., Kono, H., Miyamoto, N., Yoshida, R., Toki, H., Matsumoto, I., Hara, M., Inoue, H., Inatsuki, A., Funatsu, T., Yamano, N., Bando, F., Iwao, E., Miyoshi, I., Hinuma, Y., & Hanaoka, M. (1989). Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. International Journal of Cancer. https://doi.org/10.1002/ijc.2910430618

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.